{"id":"W7141300528","doi":"10.1093/immadv/ltaf031","title":"Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study","year":2025,"lang":"en","type":"article","venue":"Immunotherapy Advances","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nivolumab; Atezolizumab; Pembrolizumab; Hazard ratio; Ipilimumab; Overall survival; Proportional hazards model; Baseline (sea); Biomarker","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001277186,0.0004768089,0.000948874,0.000580092,0.0005437015,0.001077811,0.0005883424,0.0005890839,0.001389875],"category_scores_gemma":[0.001980973,0.0004978359,0.001317055,0.0012894,0.0003730235,0.000760542,0.0007850743,0.000983775,0.00035506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004972962,"about_ca_system_score_gemma":0.0004283152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004250044,"about_ca_topic_score_gemma":0.004483101,"domain_scores_codex":[0.9989474,0.0002593851,0.0001047559,0.0003827768,0.0001518174,0.0001537779],"domain_scores_gemma":[0.9984211,0.0002122893,0.0005765011,0.000273765,0.0001909894,0.000325332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007193048,0.00005468825,0.9979262,0.00001468948,0.0002310983,0.00007028769,0.00005751193,0.00005408194,0.0002415925,0.000009685019,0.0001146592,0.000506167],"study_design_scores_gemma":[0.00005963009,0.0003760204,0.9986381,0.000007326352,0.0001214933,0.0001844709,0.0001192748,0.0002668594,0.00004107135,0.00001556878,0.0001612686,0.000008946487],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990026,0.0001676883,0.00008095138,0.00001598485,0.000006136971,0.00002314793,0.0005607456,0.000002256921,0.0001403806],"genre_scores_gemma":[0.9991246,0.00005528075,0.00005272537,0.00001909594,0.00001275197,0.00002155534,0.0006354244,0.000002463209,0.00007612589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004250044,"threshold_uncertainty_score":0.008450627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004670248094513474,"score_gpt":0.2520719266116027,"score_spread":0.2474016785170892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}